Published in J Virol on December 01, 1990
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc Natl Acad Sci U S A (1992) 1.50
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J Virol (1991) 1.37
A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence. J Virol (1992) 1.30
Determinants of persistence and demyelination of the DA strain of Theiler's virus are found only in the VP1 gene. J Virol (1991) 1.27
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J Virol (1997) 1.20
Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J Virol (2000) 1.18
Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence. J Virol (1992) 1.13
Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J Virol (1992) 1.11
A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses. J Virol (1998) 1.10
Influence of the Theiler's virus L* protein on macrophage infection, viral persistence, and neurovirulence. J Virol (2000) 1.10
Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol (1994) 1.05
The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells. J Virol (1995) 1.05
Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J Virol (1993) 1.01
The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons. J Virol (1998) 0.95
Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence. J Virol (1993) 0.94
The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells. J Virol (1995) 0.92
Apoptotic and antiapoptotic activity of L protein of Theiler's murine encephalomyelitis virus. J Virol (2011) 0.87
Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway. J Virol (2010) 0.87
An attenuated variant of the GDVII strain of Theiler's virus does not persist and does not infect the white matter of the central nervous system. J Virol (1999) 0.86
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun (1975) 7.12
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol (1987) 3.77
Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J Virol (1985) 3.67
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology (1988) 3.17
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol (1980) 3.04
Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1989) 2.31
Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci (1976) 2.20
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol (1981) 1.87
Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol (1988) 1.72
Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun (1979) 1.50
Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med (1989) 1.39
Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J Virol (1988) 1.31
Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology (1986) 1.30
Multiple sclerosis. N Engl J Med (2000) 12.69
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20
Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science (1993) 5.78
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol (1992) 3.53
Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis (2001) 3.42
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology (1988) 3.17
Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol (2012) 2.96
Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet (1992) 2.69
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
A mutation in the voltage-gated sodium channel gene associated with pyrethroid resistance in Latin American Aedes aegypti. Insect Mol Biol (2007) 2.60
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol (1983) 2.60
Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci (1997) 2.44
Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN. Neurology (1998) 2.38
Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax (1998) 2.33
Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology (1998) 2.26
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med (1997) 2.19
Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
White-light filaments for atmospheric analysis. Science (2003) 2.07
Regulating the interpersonal self: strategic self-regulation for coping with rejection sensitivity. J Pers Soc Psychol (2000) 2.05
Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem (1994) 2.04
Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol (1985) 1.98
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys (1994) 1.94
Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci U S A (1994) 1.94
Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science (1982) 1.88
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83
Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1991) 1.79
Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci (1998) 1.78
Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology (1995) 1.76
The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain (2001) 1.70
Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology (2000) 1.67
A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology (1990) 1.66
Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int (2007) 1.65
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63
DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann Neurol (1984) 1.62
Antimitochondrial antibodies in jaundice following drug administration. JAMA (1969) 1.61
The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J Virol (1995) 1.60
The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol (1982) 1.57
Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J (2001) 1.56
Okadaic acid, a protein phosphatase inhibitor, blocks calcium changes, gene expression, and cell death induced by gibberellin in wheat aleurone cells. Plant Cell (1996) 1.56
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology (2003) 1.56
Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin. Eur J Neurol (2010) 1.55
Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology (1986) 1.55
Engineering a homo-ethanol pathway in Escherichia coli: increased glycolytic flux and levels of expression of glycolytic genes during xylose fermentation. J Bacteriol (2001) 1.55
Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. Mayo Clin Proc (1992) 1.53
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int (2007) 1.53
Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci U S A (1994) 1.52
Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology (2004) 1.51
Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J Virol (1991) 1.50
Teaching community-oriented primary care through longitudinal group projects. Fam Med (1998) 1.50
Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol (1989) 1.49
Isoelectric focusing studies of serum and cerebrospinal fluid in patients with antecedent poliomyelitis. Ann Neurol (1989) 1.48
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.46
Virus-induced abortion. Studies of equine herpesvirus 1 (abortion virus) in hamsters. Lab Invest (1975) 1.45
Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol (1992) 1.44
The influence of acute and chronic hypercalcemia on the parathyroid hormone response to hypocalcemia in rabbits. Eur J Endocrinol (2002) 1.44
Human T-cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis. Mayo Clin Proc (1991) 1.43
Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Acta Cytol (1999) 1.43
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J Virol (1985) 1.41
Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program. Am J Clin Nutr (1980) 1.40
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
An ideR mutant of Mycobacterium smegmatis has derepressed siderophore production and an altered oxidative-stress response. Mol Microbiol (1996) 1.39
The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1999) 1.38
[Is aggressiveness really inhibited in asthmatic adolescents? An epidemiological approach]. Rev Mal Respir (2001) 1.38
Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1982) 1.37
Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37
Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). Am J Pathol (1983) 1.37
Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2002) 1.35
Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest (1983) 1.34
Literacy promotion for Hispanic families in a primary care setting: a randomized, controlled trial. Pediatrics (1999) 1.33
A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J Virol (1998) 1.32
Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer (2012) 1.32
A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat Med (1995) 1.31
Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J Virol (1988) 1.31
Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology (2004) 1.30
Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology (1986) 1.30
YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-kappa B during acute-phase response. Mol Cell Biol (1994) 1.28
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature (1980) 1.28
Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat (2008) 1.27
Viral perturbation of endocrine function: disordered cell function leads to disturbed homeostasis and disease. Nature (1984) 1.27
CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol (1998) 1.27
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology (2005) 1.26
Structural mutation affecting intracellular transport and cell surface expression of murine class II molecules. J Exp Med (1988) 1.26
Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci (1999) 1.24
Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest (1986) 1.24
Retinocochleocerebral vasculopathy. Medicine (Baltimore) (1998) 1.23
Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol (1996) 1.23
Gel electrophoretic analysis of Zymomonas mobilis glycolytic and fermentative enzymes: identification of alcohol dehydrogenase II as a stress protein. J Bacteriol (1991) 1.22